Suppr超能文献

内源性一氧化氮减弱大鼠主动脉中β-肾上腺素能受体介导的舒张作用。

Endogenous nitric oxide attenuates beta-adrenoceptor-mediated relaxation in rat aorta.

作者信息

Kang Khong Bee, van der Zypp Andrea, Majewski Henryk

机构信息

School of Medical Sciences, RMIT University, Melbourne, Victoria, Australia.

出版信息

Clin Exp Pharmacol Physiol. 2007 Jan-Feb;34(1-2):95-101. doi: 10.1111/j.1440-1681.2007.04536.x.

Abstract
  1. Divergent evidence suggests that the intracellular signalling pathways for beta-adrenoceptor-mediated vascular relaxation involves either cAMP/protein kinase (PK) A or endothelial nitric oxide (NO) release and subsequent activation of cGMP/PKG. The present study identifies the relative roles of NO and cAMP, as well as dependence on the endothelium for beta-adrenoceptor-mediated relaxation of rat isolated aortas. 2. Cumulative concentration-response curves to isoprenaline (0.01-3 micromol/L) in phenylephrine (0.1 micromol/L)-preconstricted endothelium-intact and -denuded aortas were constructed. Isoprenaline-mediated relaxation was partially reduced by endothelium removal and the presence of the NO synthase inhibitor N(G)-monomethyl-L-arginine (0.1 mmol/L), but not by the cAMP antagonist (Rp)-cyclic adenosine-3',5'-monophosphorothioate (Rp-cAMPS; 0.5 mmol/L). 3. In contrast, in endothelium-denuded aortas, the isoprenaline-mediated relaxation was inhibited by Rp-cAMPS and this inhibition was lost in the presence of the NO donor sodium nitroprusside (1 nmol/L). This effect was not due to phosphodiesterase (PDE) activity because the non-selective PDE inhibitor 3-isobutyl-1-methylxanthine (1 micromol/L) failed to affect the isoprenaline vasorelaxant response. 4. The K(+) channel blocker tetraethylammonium (TEA; 1 mmol/L) attenuated isoprenaline-induced relaxation in endothelium-denuded aorta, but its effect was non-additive with Rp-cAMPS, suggesting that the K(+) channel component may involve cAMP. In endothelium-intact aortas, TEA but not Rp-cAMPS reduced isoprenaline relaxation, suggesting an additional non-cAMP component. 5. These findings suggest that beta-adrenoceptors induce vascular smooth muscle relaxation by acting through the NO-cGMP pathway and, when that is disrupted by endothelium removal or the presence of an NO synthase inhibitor, the cAMP pathway in smooth muscles is used. The lack of cAMP participation in endothelium-intact vessels may be because NO suppresses or overrides the cAMP effect.
摘要
  1. 相互矛盾的证据表明,β-肾上腺素能受体介导的血管舒张的细胞内信号通路涉及cAMP/蛋白激酶(PK)A或内皮型一氧化氮(NO)释放以及随后cGMP/PKG的激活。本研究确定了NO和cAMP的相对作用,以及β-肾上腺素能受体介导的大鼠离体主动脉舒张对内皮的依赖性。2. 构建了去氧肾上腺素(0.1 μmol/L)预收缩的内皮完整和去内皮主动脉对异丙肾上腺素(0.01 - 3 μmol/L)的累积浓度-反应曲线。内皮去除和存在NO合酶抑制剂N(G)-单甲基-L-精氨酸(0.1 mmol/L)会部分降低异丙肾上腺素介导的舒张,但cAMP拮抗剂(Rp)-环腺苷-3',5'-单磷酸硫代酸盐(Rp-cAMPS;0.5 mmol/L)不会。3. 相反,在去内皮主动脉中,Rp-cAMPS抑制异丙肾上腺素介导的舒张,而在存在NO供体硝普钠(1 nmol/L)时这种抑制作用消失。这种效应不是由于磷酸二酯酶(PDE)活性,因为非选择性PDE抑制剂3-异丁基-1-甲基黄嘌呤(1 μmol/L)未能影响异丙肾上腺素的血管舒张反应。4. K(+)通道阻滞剂四乙铵(TEA;1 mmol/L)减弱了去内皮主动脉中异丙肾上腺素诱导的舒张,但其作用与Rp-cAMPS无相加性,表明K(+)通道成分可能涉及cAMP。在内皮完整的主动脉中,TEA而非Rp-cAMPS降低了异丙肾上腺素的舒张,提示存在额外的非cAMP成分。5. 这些发现表明,β-肾上腺素能受体通过NO-cGMP途径诱导血管平滑肌舒张,当该途径因内皮去除或NO合酶抑制剂的存在而中断时,平滑肌中的cAMP途径被利用。cAMP在内皮完整的血管中不参与可能是因为NO抑制或超越了cAMP的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验